This post has been archived and contains information that may be out of date.
On Jan. 5, the Centers for Disease Control and Prevention (CDC) endorsed the recommendation made earlier that day by its Advisory Committee on Immunization Practices that eligibility for a single booster dose of the Pfizer-BioNTech vaccine be expanded to ages 12-15.
This content is restricted to members.
